MDK and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), MDK mediates anoikis resistance to the circulatory tumor cells (CTCs) and enhances tumor metastasis and relapse upon binding to ALK receptors through the PI3K/Akt/NFκB/TrkB axis, which makes a positive feedback loop [23].